Point State Capital LP Insmed Inc Transaction History
Point State Capital LP
- $4.56 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
484Shares Held
187MCall Options Held
2.15MPut Options Held
3.22M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.43 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.12 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$990 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$826 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$560 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.7B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...